sameAs
Left Atrial Enlargement in Young High-Level Endurance Athletes - Another Sign of Athlete's Heart?Standards of statin usage in Poland in high-risk patients: 3ST-POL study results.Reference values of maximal oxygen uptake for polish rowers.Simultaneous predictive value of NT-proBNP and CA-125 in patients newly diagnosed with advanced heart failure: preliminary resultsThe influence of systematic pulse-limited physical exercise on the parameters of the cardiovascular system in patients over 65 years of agePoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.[A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population].[Combination therapy in the management of hypertension - current problem in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy].[Optimal model of comprehensive rehabilitation and secondary prevention].Peripartum cardiomyopathy - from pathogenesis to treatment.Status of etoricoxib in the treatment of rheumatic diseases. Expert panel opinion.[Type 2 diabetes prevention. Experts' Group position paper endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy].Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term RegistryThe influence of extreme mixed exertion load on the right ventricular dimensions and function in elite athletes: a tissue Doppler study[Actual problems of dyslipidaemia treatment in Poland - 2nd Declaration of Sopot. Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy][Fondaparinux in the treatment of acute coronary syndromes in Poland--from theory to practice. Experts' group position paper endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy][Rola układu wazopresynergicznego w zespole metabolicznym][Loop diuretics: old and new ones--which one to choose in clinical practice? Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy and Working Group on Heart Failure]Sudden cardiac death in athletesThe influence of metabolic syndrome coexistence on the prognosis of patients with heart failure without atrial fibrillation. Analysis of Polish data from the pilot survey for the ESC Heart Failure RegistryDifferences in achieving treatment goals with statin use in various regions of Poland--3ST-POL study results
P50
Q30364547-64E48ED6-AD09-44E9-B677-8F425F95A38DQ34663123-669E2EC4-9D96-4DC7-9A1E-FC6F864164FBQ35081596-7027C02D-70CB-4947-9509-4CB519599C79Q36286287-47E894CF-856B-49D2-8FBA-0F78B70DAA32Q36829061-93821182-A6A9-402E-BF42-31EFFE02AEA1Q37549374-B662AB61-95C3-4E33-8676-4EAEDA84480CQ41161581-7EB2A683-8F42-48B6-9418-7D3383C4BEA6Q44506032-EFFC4974-D1C6-4B43-9B51-AB0B1F0F496AQ45083555-65DBD9E3-1546-4AC7-AE5A-EFBEC6F8A8C9Q53302306-2E4F3002-70A8-4832-A365-9A84C38E4E9FQ53602109-FD946D8D-B63E-418A-8AC8-5CCF14590F59Q53659090-2BE8CC47-6E50-452C-878F-CB584F06EFFFQ57628379-2486767B-9B6A-4DFE-BA71-70CB19D956D2Q84201607-84B70802-DA4F-4838-B219-41FCCB5F4B7EQ85329189-0707055C-EF89-48B8-A561-581577400A44Q86598328-D79DA041-2EB3-406F-B427-F8B0D7435EDAQ86907420-BC742DC8-8A19-4438-8DAE-67557E4DDA08Q86962136-22F8C6A9-6492-469E-8670-2EBF941E9FBBQ87334710-361B2A0A-7A09-4F31-8B26-1BE551E97974Q88350349-30689FC0-BA1E-40C9-87E4-6538EFD28221Q89048244-094F2F0F-D8E4-4CB0-8E77-C25B759B61BF
P50
description
Polish cardiologist and internist
@en
cardioloog
@nl
polski lekarz, kardiolog, internista
@pl
name
Artur Mamcarz
@ast
Artur Mamcarz
@ca
Artur Mamcarz
@cs
Artur Mamcarz
@de
Artur Mamcarz
@en
Artur Mamcarz
@es
Artur Mamcarz
@fr
Artur Mamcarz
@gl
Artur Mamcarz
@hr
Artur Mamcarz
@hsb
type
label
Artur Mamcarz
@ast
Artur Mamcarz
@ca
Artur Mamcarz
@cs
Artur Mamcarz
@de
Artur Mamcarz
@en
Artur Mamcarz
@es
Artur Mamcarz
@fr
Artur Mamcarz
@gl
Artur Mamcarz
@hr
Artur Mamcarz
@hsb
altLabel
Artur Jacek Mamcarz
@pl
prefLabel
Artur Mamcarz
@ast
Artur Mamcarz
@ca
Artur Mamcarz
@cs
Artur Mamcarz
@de
Artur Mamcarz
@en
Artur Mamcarz
@es
Artur Mamcarz
@fr
Artur Mamcarz
@gl
Artur Mamcarz
@hr
Artur Mamcarz
@hsb
P1153
7003671337
P1412
P1559
Artur Mamcarz
@pl
P19
P21
P214
71147965644184080162
P27
P31
P3124
P496
0000-0002-9569-1486
P569
1958-07-30T00:00:00Z
P7859
viaf-71147965644184080162